GIVAUDAN : UBS lowers its price target
'UBS is 2%/3% ahead of consensus for comparable EBITDA 2024/2025', says the analyst firm.
In the medium to long term, Givaudan is targeting like-for-like sales growth of 4-5% and free cash flow of at least 12%, both indicators being measured on average over the five-year strategic cycle.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.
Go to the original article.
Contact us to request a correction